Submit Your Feeds

Business News • PR NewsWire • Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval

Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval
Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval

SAN DIEGO, July 1, 2010 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and sup

View More : http://www.prnewswire.com/news-releases/eisai-to-market-arena-pharmaceuticals-lorcaserin-for-obesity-and-weight-manageme...
Releted News by prnewswire
Robert W. Jordan Returns to Region as Partner in Charge -- Middle East Offices for Baker Botts L.L.P.
New Swedish Traceability Technology Can Revolutionize the Global Forestry Industry
PAAMCO Names Four New Partners
Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval
New Wind of Opportunities in the Wind Energy Sector in Europe, Finds Frost & Sullivan
Elsevier Appoints Martin O'Malley as Managing Director of New Global Sales Group in Science & Technology Division
Home Sitemap Contact Us
© businessNewsNewsNews.com